Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Loriot Y, Fizazi K, de Bono JS, Forer D, et al. Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial. Cancer 2016 Sep 20. doi: 10.1002/cncr.30336.
PMID: 27648814

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016